Marillyn A. Hewson - 04 Mar 2025 Form 4 Insider Report for JOHNSON & JOHNSON (JNJ)

Role
Director
Signature
/s/ Joleen Morgan, as attorney-in-fact for Marillyn A. Hewson
Issuer symbol
JNJ
Transactions as of
04 Mar 2025
Net transactions value
$0
Form type
4
Filing time
12 Mar 2026, 21:31:29 UTC
Previous filing
05 Mar 2025
Next filing
28 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HEWSON MARILLYN A Director ONE JOHNSON & JOHNSON PLAZA, NEW BRUNSWICK /s/ Joleen Morgan, as attorney-in-fact for Marillyn A. Hewson 12 Mar 2026 0001217496

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction JNJ Deferred Share Units Award +75 +0.53% $166.10* 14,306 04 Mar 2025 Common Stock 75 Direct F1, F2
transaction JNJ Deferred Share Units Award +206 +1.4% $242.14* 14,513 10 Mar 2026 Common Stock 206 Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the acquisition of Deferred Share Units (DSUs) for deferral of cash retainer under the Issuer's Amended and Restated Deferred Fee Plan for Directors (the "Plan") that were not previously reported. DSUs are to be settled in cash upon termination of the Reporting Person's Directorship. Each DSU represents the fair market value of one share of Common Stock on the business day prior to settlement date.
F2 Includes dividend equivalent rights in connection with the Issuer's quarterly dividend and accrued to the Reporting Person on DSUs held by the Reporting Person.
F3 Acquisition of DSUs for deferral of cash retainer under the Plan.